We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Genetic Cause Found for Rare Aggressive Ovarian Cancer

By LabMedica International staff writers
Posted on 09 Apr 2014
Print article
Image: Histopathology of small cell carcinoma of the ovary, hypercalcemic type; the tumor cells are arranged in small nests (Photo courtesy of Dr. Dharam Ramnani).
Image: Histopathology of small cell carcinoma of the ovary, hypercalcemic type; the tumor cells are arranged in small nests (Photo courtesy of Dr. Dharam Ramnani).
The genetic cause of a rare type of ovarian cancer known as small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), that most often strikes girls and young women has been revealed.

This type of cancer, SCCHOT, usually is not diagnosed until it is in its advanced stages and it does not respond to standard chemotherapy, and 65% of patients die within two years. It can affect girls as young as 14 months, and women as old as 58 years, with a mean age of only 24 years old.

An international team led by the Translational Genomics Research Institute (TGen; Phoenix, AZ, USA) analyzed the genetic etiology of SCCOHT by performing next-generation sequencing on a series of tumors and germline samples from 12 SCCOHT cases. This included nine tumors with four matched germline samples and three additional germline samples, and on the SCCOHT cell line BIN-67. DNA from tumor and blood specimens was analyzed using whole-genome sequencing and whole-exome sequencing.

Genomic DNA from each sample was fragmented to a target size of 300 to 350 base pairs (bp). After ligation, samples were run on a gel to separate products and the products were quantified using the High-Sensitivity DNA chip on an Agilent 2100 Bioanalyzer (Santa Clara, CA, USA). A tissue microarray (TMA) representing nine SCCOHT cases was fabricated at TGen for the study. Protein blot analysis was performed on whole cell extracts.

The scientists identified frequent germline and somatic gene SWItch/Sucrose NonFermentable (SWI/SNF) Related, Matrix Associated, Actin Dependent Regulator of Chromatin, Subfamily A, Member 4 (SMARCA4) mutations and SMARCA4 protein loss in SCCOHT. The loss of SMARCA4 protein expression is extremely specific to SCCOHT and can facilitate the differential diagnosis of SCCOHT.

Jeffrey Trent, PhD, President and Research Director of TGen, and the study's senior author, said, “This is a thoroughly remarkable study. Many genetic anomalies can be like a one-lane road to cancer; difficult to negotiate. But these findings indicate a genetic superhighway that leads right to this highly aggressive disease. The correlation between mutations in SMARCA4 and the development of SCCOHT is simply unmistakable.” The study was published on March 23, 2014, in the journal Nature Genetics.

Related Links:

Translational Genomics Research Institute
Agilent


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.